Loading organizations...
NRL Capital operates as a global investment and fund management platform, specializing in integrating top-tier industry resources with long-term capital. The firm facilitates investment and growth across various sectors by engaging with leading industry players and financial institutions to deploy capital effectively. Its multi-faceted approach aims to leverage established networks and expertise for strategic capital allocation.
The firm was established in 2020 by co-founders Xianghong LIN and Shuang DENG. Their combined vision for NRL Capital emerged from a recognition of the growing need to bridge domestic and international industry expertise with robust financial backing. This insight led to the creation of a platform designed to connect diverse capital sources with promising opportunities across its operational hubs.
NRL Capital serves a broad clientele, including institutional investors and enterprises seeking strategic capital and growth partnerships. The company’s long-term vision centers on cultivating a dynamic ecosystem where capital, innovation, and industry leadership converge. It aims to drive sustainable value creation within its portfolio and for its partners on a global scale.
NRL Capital has 2 tracked investments across 2 companies. The latest tracked deal is $200.0M Series C in NTx in August 2022.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Aug 2, 2022 | NTx | $200.0M Series C | Shaoqiang (gary) Liu, CFA | — |
| May 19, 2021 | Duality Biologics | $90.0M Series B | YI SHI | Green Pine Capital Partners, Huagai Capital, Oriza Holdings, WuXi Biologics, Yunion Healthcare Ventures |